|
2024
|
P/S
|
Pharmaceuticals for the treatment and prevention of cancer,
psychiatric diseases and disorders, ... |
|
|
P/S
|
Pharmaceuticals for the treatment and prevention of cancer, psychiatric diseases and disorders, c... |
|
|
P/S
|
Pharmaceutical preparations for the treatment of cancer; pharmaceutical preparations for use in o... |
|
|
P/S
|
Pharmaceutical preparations for the treatment of cancer;
pharmaceutical preparations for use in ... |
|
|
Invention
|
Pyrazolo[4,3-f]quinazoline derivatives as modulators of g12d mutant kras useful for the treatment... |
|
|
P/S
|
Pharmaceutical preparations for the treatment of cancer; Pharmaceutical preparations for use in o... |
|
|
P/S
|
Educational services, namely, providing educational speakers, classes, workshops, conferences, an... |
|
|
P/S
|
Providing medical information; Providing online medical information; Providing a website featurin... |
|
|
Invention
|
Ghb dosing.
Provided herein are methods of administering GHB formulations for the treatment of n... |
|
|
Invention
|
Treatment of hematological disorders.
The invention relates to compositions and methods for trea... |
|
|
Invention
|
Modulators of nanoparticle uptake. Various formulations for combination therapy with a liposome a... |
|
|
Invention
|
Interferon prodrugs. This disclosure relates to methods and compositions for treating cancer usin... |
|
|
Invention
|
Methods of treating solid tumors with mitogen activated protein kinase (mapk) pathway alterations... |
|
|
Invention
|
Macrocyclic orexin receptor agonists and uses thereof. Provided herein are compounds of Formula (... |
|
2023
|
Invention
|
Crystalline forms of (s)-5-((3-(4-(4-fluorophenyl)-1h-imidazol-2-yl)chroman-6-yl)oxy)-3,4-dihydro... |
|
|
Invention
|
Fused bicyclic raf inhibitors and methods for use thereof.
The present disclosure generally rela... |
|
|
Invention
|
Defibrotide for use in preventing and treating sepsis. The present disclosure provides methods of... |
|
|
Invention
|
Ghb formulation and method for its manufacture.
The present application relates to GHB formulati... |
|
|
Invention
|
Modified l-asparaginase.
The disclosure provides a modified protein that is a combination of (i)... |
|
|
Invention
|
Substituted heterocycles as ras inhibitors. Provided herein are compounds identified as inhibitor... |
|
|
Invention
|
Biaryl ether urea compounds.
The disclosure is directed to compounds of Formula (I) and pharmace... |
|
|
Invention
|
Biaryl ether urea compounds as faah inhibitors. The disclosure is directed to compounds of Formul... |
|
|
Invention
|
Combination therapies involving l-asparaginase. The present disclosure provides compositions and ... |
|
|
Invention
|
Gamma-hydroxybutyrate compositions and their uses for the treatment of disorders.
Provided herei... |
|
|
Invention
|
Macrocyclic orexin receptor agonists and uses thereof. 123412344, Formula (II), (II), V, X, Y and... |
|
|
P/S
|
Pharmaceutical preparations for the treatment of cancer; pharmaceutical preparations for the trea... |
|
|
Invention
|
Tricyclic phthalazines and derivatives as sos1 inhibitors. The present disclosure provides compou... |
|
|
Invention
|
Novel amine-substituted phthalazines and derivatives as sos1 inhibitors. The present disclosure p... |
|
|
Invention
|
Method of administering oxybate. Provided herein are methods of administering different GHB forms... |
|
2022
|
P/S
|
Pharmaceuticals, medical and veterinary preparations;
sanitary preparations for medical purposes... |
|
|
Invention
|
Method of administering oxybate.
Provided herein are methods of administering different GHB form... |
|
|
P/S
|
Pharmaceuticals, medical and veterinary preparations; sanitary preparations for medical purposes;... |
|
|
Invention
|
Method of treating posttraumatic stress disorder.
This disclosure provides methods for treating ... |
|
|
Invention
|
Method of treating posttraumatic stress disorder. This disclosure provides methods for treating a... |
|
|
Invention
|
Gamma-hydroxybutyrate compositions and their use for the treatment of disorders.
Provided herein... |
|
|
Invention
|
Sulfonamide orexin receptor agonists and uses thereof.
Provided herein are compounds of Formula ... |
|
|
Invention
|
Sulfonamide orexin receptor agonists and uses thereof. Provided herein are compounds of Formula (... |
|
|
Invention
|
Sulfonamide orexin receptor agonists and uses thereof. 1234122, Y and Z are defined herein. Also ... |
|
|
Invention
|
Defibrotide for the treatment and prevention of acute respiratory distress syndrome. The present ... |
|
|
Invention
|
Orexin receptor agonists and uses thereof.
Provided herein are compounds of Formula (I), or phar... |
|
|
Invention
|
Orexin receptor agonists and uses thereof. 123456121233, Y and Z are defined herein. Also provide... |
|
|
Invention
|
Orexin receptor agonists and uses thereof. Provided herein are compounds of Formula (I), or pharm... |
|
|
Invention
|
Formulations of l-asparaginase.
Provided herein are stable, aqueous, non-lyophilized formulation... |
|
|
Invention
|
Formulations of l-asparaginase. Provided herein are stable, aqueous, non-lyophilized formulations... |
|
|
Invention
|
Dosing and administration of recombinant l-asparaginase.
The present invention provides composit... |
|
|
Invention
|
Dosing and administration of recombinant l-asparaginase. The present invention provides compositi... |
|
|
P/S
|
Pharmaceutical preparations for the treatment of cancer;
pharmaceutical preparations for the tre... |
|
2021
|
Invention
|
Methods of purifying charge-shielded fusion proteins.
The present invention relates to method of... |
|
|
Invention
|
Treatment methods using ghb.
Provided herein are methods of treating fibromyalgia, post-traumati... |
|
|
Invention
|
Sodium oxybate to treat idiopathic hypersomnia.
The present disclosure relates to methods of tre... |
|
|
Invention
|
Dosing of recombinant l-asparaginase. The present invention provides compositions and methods for... |
|
|
Invention
|
Dosing of recombinant l-asparaginase.
The present invention provides compositions and methods fo... |
|
|
Invention
|
Defibrotide treatment for the prevention of organ rejection and injury.
The present disclosure p... |
|
|
Invention
|
Delivery of low viscosity formulations.
Low-viscosity nucleic acid compositions that can be admi... |
|
|
Invention
|
Ras inhibitors and methods of using the same.
Provided herein are compounds identified as inhibi... |
|
2018
|
Invention
|
Methods of treatment with asparaginase.
The invention relates to methods of treating diseases wi... |
|
2017
|
Invention
|
Fused bicyclic (hetero)aromatic compounds useful for the treatment of cancers. This invention rel... |
|
2004
|
P/S
|
Pharmaceutical preparations for the treatment of schizophrenia |
|
2002
|
P/S
|
Pharmaceutical preparations |
